Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-23

Clinical Trial Update: A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients [Phase 1]

View source ↗

Summary

Phase 1 study comparing plasma levels of levodopa, carbidopa, and entacapone after TRIGEL infusion versus Duodopa infusion in Parkinson's disease patients; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa (Carbidopa)
  • Entacapone (Entacapone)
  • levodopa (levodopa)

Snippet

Sponsor: LobSor Pharmaceuticals AB | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED | Results posted: 2016-05-23